Research and development of medicines
Development and introduction in manufacture of innovative and reproduced synthetic and biotechnological Medicinal products "on a turn-key basis"
Investment activities
Investing in the development of innovative drugs; joint development of the projects of the ChemRar portfolio on partner terms; licensing and transfer of rights to the results of intellectual activity

«ChemRar» High-Tech center:

We develop and manufacture effective, safe and affordable medicines for the treatment of socially significant diseases and improvement of the quality of life:

• Using experience and global standards at all stages of creation of a novel medicine;

• Contributing to the development of the scientific and technological potential of the pharmaceutical industry in Russia;

• Applying our knowledge to search for optimal solutions for our partners.

NEWS

The winners of the sixth annual National Rating of Russian High-Tech Rapidly Developing Companies TechUspekh-2017, organized by RVC together with PwC, the Association of Innovative Regions of Russia and the National Research University Higher School of Economics, were announced on December 12, 2017. Data for more than one hundred domestic ...

21.12.2017
The Award Ceremony for the domestic pharmaceutical and medical industry institutional awards of the Ministry of Industry and Trade of the Russian Federation was held at the opening ceremony of the Russian Health Care Week 2017 on December 4, 2017. Irina Tyrnova, who has headed Viriom since its founding in 2009, and under whose supervision ELPIDA® ...

08.12.2017
In early November, IPHARMA, a company of ChemRar Group, received two approvals from the Ministry of Healthcare of the Russian Federation to conduct phase I clinical trials of Ventvil® and Slavinorm®. Protocol No. HEP-VTL-01 “A double-blind, randomized, placebo-controlled trial of the safety and tolerability of increasing doses of Ventvil® in ...

17.11.2017
On November 14–16, the 21st Russian Oncology Congress was held in Moscow. It is the largest international event in the field of oncology, which is attended by over 5,000 doctors annually. The permanent organizers of the Congress: N.N. Blokhin Russian Cancer Research Center and the Russian Society of Clinical Oncology under the aegis of the ...

16.11.2017
All news
Get the latest pharma news delivered to your inbox
  
I agree to the processing of personal data. Privacy policy